FLC Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Hold
1,111
0.21% 71
2026
Q1
$1.02M Sell
1,111
-56
-5% -$56.8K 0.18% 75
2025
Q4
$1.25M Buy
1,167
+26
+2% +$24.9K 0.23% 66
2025
Q3
$871K Buy
1,141
+30
+3% +$22.3K 0.17% 80
2025
Q2
$866K Buy
1,111
+91
+9% +$70.7K 0.18% 76
2025
Q1
$842K Sell
1,020
-14
-1% -$11.6K 0.19% 79
2024
Q4
$798K Sell
1,034
-95
-8% -$78.7K 0.18% 77
2024
Q3
$1M Sell
1,129
-10
-0.9% -$8.99K 0.23% 61
2024
Q2
$1.03M Sell
1,139
-45
-4% -$36K 0.25% 56
2024
Q1
$921K Sell
1,184
-18
-1% -$12.8K 0.23% 60
2023
Q4
$701K Hold
1,202
0.19% 76
2023
Q3
$646K Sell
1,202
-66
-5% -$34K 0.2% 77
2023
Q2
$595K Sell
1,268
-10
-0.8% -$4.19K 0.17% 82
2023
Q1
$439K Hold
1,278
0.13% 100
2022
Q4
$468K Sell
1,278
-18
-1% -$6.38K 0.15% 99
2022
Q3
$419K Sell
1,296
-467
-26% -$148K 0.15% 106
2022
Q2
$572K Hold
1,763
0.19% 95
2022
Q1
$505K Hold
1,763
0.14% 106
2021
Q4
$487K Hold
1,763
0.14% 117
2021
Q3
$407K Hold
1,763
0.12% 120
2021
Q2
$405K Hold
1,763
0.12% 121
2021
Q1
$329K Sell
1,763
-100
-5% -$19.6K 0.1% 129
2020
Q4
$315K Buy
+1,863
New +$278K 0.1% 114
2020
Q2
Sell
-1,540
Closed -$219K 131
2020
Q1
$219K Buy
+1,540
New +$212K 0.1% 101

Other funds holding LLY

FLC Capital Advisors's LLY Position: Q2 2026 in Review

FLC Capital Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 1,111 shares worth $1.33M. The position accounts for 0.21% of the portfolio, ranked #71.

FLC Capital Advisors first reported a position in LLY in Q1 2020 and has held it in 24 quarters since. 1,717 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • FLC Capital Advisors held 1,111 shares of Eli Lilly worth $1.33M as of Q2 2026.
  • FLC Capital Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.21% of FLC Capital Advisors's portfolio in Q2 2026, its #71 holding.
  • FLC Capital Advisors first reported a position in Eli Lilly in Q1 2020 and has held it in 24 quarters since.
  • 1,717 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on FLC Capital Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.